Tessenderlo, Belgium

Sofie Jeanne Leopoldine Celen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.8

ph-index = 1


Location History:

  • Leuven, BE (2020)
  • Tessenderlo, BE (2014 - 2021)

Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sofie Jeanne Leopoldine Celen: Innovator in Pharmaceutical Sciences

Introduction

Sofie Jeanne Leopoldine Celen is a prominent inventor based in Tessenderlo, Belgium. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for medical imaging and treatment.

Latest Patents

Celen holds three patents, showcasing her innovative work. Her latest patents include "Radiolabelled mGluR2 PET ligands," which relates to selective radiolabelled mGluR2 ligands useful for imaging and quantifying the metabotropic glutamate receptor mGluR2 in tissues using positron-emission tomography (PET). This invention also encompasses compositions and processes for preparing these compounds, as well as their applications in imaging tissues, cells, or mammals. Another notable patent is for "1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives," which are inhibitors of phosphodiesterase 2 (PDE2) and phosphodiesterase 10 (PDE10). This invention includes pharmaceutical compositions and methods for treating disorders related to these enzymes, along with radiolabelled compounds for imaging PDE2 in tissues.

Career Highlights

Celen is currently associated with Janssen Pharmaceutica NV, where she continues to advance her research and development efforts. Her work has positioned her as a key figure in the pharmaceutical industry, contributing to innovative solutions for complex medical challenges.

Collaborations

Some of her notable coworkers include José Ignacio Andrés-Gil and Guy Maurits R Bormans. Their collaborative efforts have further enhanced the impact of her inventions in the field.

Conclusion

Sofie Jeanne Leopoldine Celen is a trailblazer in pharmaceutical innovation, with a focus on developing advanced compounds for medical applications. Her contributions are paving the way for future advancements in medical imaging and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…